Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2020
Headcount
5
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
Taxon Therapeutics is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins for rare autoimmune diseases with unmet need. The company's product, TAX-01, is designed for the treatment of adults with autoimmune hemolytic anemia, a severe and rare blood disorder that occurs when antibodies directed against the person's own red blood cells cause them to burst, leading to an insufficient number of oxygen-carrying red blood cells in circulation.
Q&A
- What is the current status of Taxon Therapeutics?
- Taxon Therapeutics is currently inactive, having ceased to operate in April 2024.
- What is Taxon Therapeutics' primary focus?
- Taxon Therapeutics is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins for rare autoimmune diseases with unmet needs.
- What is the main product of Taxon Therapeutics?
- Taxon Therapeutics' product, TAX-01, is designed for the treatment of adults with autoimmune hemolytic anemia, a severe and rare blood disorder.
- When was Taxon Therapeutics founded?
- Taxon Therapeutics was founded in June 2020.
- How many employees does Taxon Therapeutics have?
- Taxon Therapeutics has 1-10 employees.
- What is the current funding stage of Taxon Therapeutics?
- Taxon Therapeutics is currently in the Pre-Funding stage.
- What sector does Taxon Therapeutics primarily operate in?
- Taxon Therapeutics primarily operates in the Health Tech & Life Sciences sector.
- Where is Taxon Therapeutics headquartered?
- Taxon Therapeutics is headquartered in Herzliya, Center District, Israel.
Team · 2
Founder · Co-founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
therapeuticsrare-diseasesbiotechnologyautoimmune-diseasespharmaceuticalsdrug-developmenthematologyorphan-drug
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2020-6 |
|---|---|
| Employees (exact) | 5 |
| Status reason | Non Active, Apr 2024 ceased to operate |